Skip to main content
Journal cover image

A national strategy to develop pragmatic clinical trials infrastructure.

Publication ,  Journal Article
Concannon, TW; Guise, J-M; Dolor, RJ; Meissner, P; Tunis, S; Krishnan, JA; Pace, WD; Saltz, J; Hersh, WR; Michener, L; Carey, TS
Published in: Clin Transl Sci
April 2014

An important challenge in comparative effectiveness research is the lack of infrastructure to support pragmatic clinical trials, which compare interventions in usual practice settings and subjects. These trials present challenges that differ from those of classical efficacy trials, which are conducted under ideal circumstances, in patients selected for their suitability, and with highly controlled protocols. In 2012, we launched a 1-year learning network to identify high-priority pragmatic clinical trials and to deploy research infrastructure through the NIH Clinical and Translational Science Awards Consortium that could be used to launch and sustain them. The network and infrastructure were initiated as a learning ground and shared resource for investigators and communities interested in developing pragmatic clinical trials. We followed a three-stage process of developing the network, prioritizing proposed trials, and implementing learning exercises that culminated in a 1-day network meeting at the end of the year. The year-long project resulted in five recommendations related to developing the network, enhancing community engagement, addressing regulatory challenges, advancing information technology, and developing research methods. The recommendations can be implemented within 24 months and are designed to lead toward a sustained national infrastructure for pragmatic trials.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Transl Sci

DOI

EISSN

1752-8062

Publication Date

April 2014

Volume

7

Issue

2

Start / End Page

164 / 171

Location

United States

Related Subject Headings

  • United States
  • Translational Research, Biomedical
  • Program Development
  • Pragmatic Clinical Trials as Topic
  • Humans
  • Health Planning Guidelines
  • General Clinical Medicine
  • 3214 Pharmacology and pharmaceutical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1199 Other Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Concannon, T. W., Guise, J.-M., Dolor, R. J., Meissner, P., Tunis, S., Krishnan, J. A., … Carey, T. S. (2014). A national strategy to develop pragmatic clinical trials infrastructure. Clin Transl Sci, 7(2), 164–171. https://doi.org/10.1111/cts.12143
Concannon, Thomas W., Jeanne-Marie Guise, Rowena J. Dolor, Paul Meissner, Sean Tunis, Jerry A. Krishnan, Wilson D. Pace, et al. “A national strategy to develop pragmatic clinical trials infrastructure.Clin Transl Sci 7, no. 2 (April 2014): 164–71. https://doi.org/10.1111/cts.12143.
Concannon TW, Guise J-M, Dolor RJ, Meissner P, Tunis S, Krishnan JA, et al. A national strategy to develop pragmatic clinical trials infrastructure. Clin Transl Sci. 2014 Apr;7(2):164–71.
Concannon, Thomas W., et al. “A national strategy to develop pragmatic clinical trials infrastructure.Clin Transl Sci, vol. 7, no. 2, Apr. 2014, pp. 164–71. Pubmed, doi:10.1111/cts.12143.
Concannon TW, Guise J-M, Dolor RJ, Meissner P, Tunis S, Krishnan JA, Pace WD, Saltz J, Hersh WR, Michener L, Carey TS. A national strategy to develop pragmatic clinical trials infrastructure. Clin Transl Sci. 2014 Apr;7(2):164–171.
Journal cover image

Published In

Clin Transl Sci

DOI

EISSN

1752-8062

Publication Date

April 2014

Volume

7

Issue

2

Start / End Page

164 / 171

Location

United States

Related Subject Headings

  • United States
  • Translational Research, Biomedical
  • Program Development
  • Pragmatic Clinical Trials as Topic
  • Humans
  • Health Planning Guidelines
  • General Clinical Medicine
  • 3214 Pharmacology and pharmaceutical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1199 Other Medical and Health Sciences